

Course Description
Gadolinium-based contrast agents (GBCAs) increase the diagnostic sensitivity of magnetic resonance imaging (MRI) by shortening the T1 relaxation time of certain tissues, improving the detection and monitoring of conditions including cancer and vascular and neurological diseases. While GBCAs have an excellent safety profile, their use still requires careful consideration of patient risk factors, potential adverse reactions, and rare long-term renal complications. Safe administration depends on MR personnel who understand GBCA chemistry and risk classification, appropriately screen patients, select the correct contrast agent and dose, and recognize and manage a patient's adverse events when they occur. This course provides MR personnel with the foundational knowledge needed to support safe GBCA use in everyday clinical practice. It begins with a review of T1 relaxation physics and how gadolinium enhances the MR signal, followed by GBCA chelate chemistry, structural classification, and risk grouping. Patient evaluation and GBCA selection are also covered, as well as a discussion of appropriate questions to ask in order to screen patients for risk factors and considerations for special populations such as pediatric, pregnant, or breastfeeding patients. The course concludes with an introduction of communication, documentation, and emergency response protocols, highlighting how each member of the MR team contributes to safe GBCA administration.
Learning Objectives
After reviewing the activity, the participant should be able to:
Categories: MRI, Imaging Assistant, MR & Safety

In order to receive CE credit, you must first review the activity content. When completed, go to the "Take CE Test!" link to access the post-test.
Submit the completed answers to determine if you have passed the post-test assessment. You must answer 9 out of 12 questions correctly to receive CE credit. You will have no more than 3 attempts to successfully complete the post-test.
Participants successfully completing the activity content and passing the post-test will receive 1.5 ARRT Category A credits.
Approved by the American Society of Radiologic Technologists for ARRT Category A credit.
Approved by the state of Florida for ARRT Category A credit (for Technical credits).
Texas direct credit (non-ionizing radiation).
This activity may be available in multiple formats or from different sponsors. ARRT does not allow CE activities such as Internet courses, home study programs, or directed readings to be repeated for CE credit in the same biennium.
| Category | Content Area | Credits |
|---|---|---|
| Magnetic Resonance | Patient Care | 1.5 |
| Radiologist Assistant | Patient Care | 1.25 |
| Vascular Interventional | Patient Care | 0.25 |

| Category | Subcategory | Credits |
|---|---|---|
| Magnetic Resonance | Patient Interactions and Management | 1.5 |
| Radiologist Assistant | Pharmacology | 1.25 |
| Vascular Interventional | Patient Interactions and Management | 0.25 |

| Category | Credits |
|---|---|
| Digital | 0 |
| Fluoroscopy | 0 |
| Mammography | 0 |

| Category | Content Area | Credits |
|---|---|---|
| IA MR | Patient Care | 1 |
| IA MR | Safety | 0.5 |
Heidi Veillette, BSc, RT(R)(MR)*
*Medical Writer, Veillette Communications; Calgary, Alberta, Canada
Address correspondence to: Heidi@VeilletteCommunications.com
Disclosure statement: The author reports having no significant financial or advisory relationships with corporate organizations related to this activity.
ABSTRACT
Gadolinium-based contrast agents (GBCAs) increase the diagnostic sensitivity of magnetic resonance imaging (MRI) by shortening the T1 relaxation time of certain tissues, improving the detection and monitoring of conditions including cancer and vascular and neurological diseases. While GBCAs have an excellent safety profile, their use still requires careful consideration of patient risk factors, potential adverse reactions, and rare long-term renal complications. Safe administration depends on MR personnel who understand GBCA chemistry and risk classification, appropriately screen patients, select the correct contrast agent and dose, and recognize and manage a patient's adverse events when they occur. This course provides MR personnel with the foundational knowledge needed to support safe GBCA use in everyday clinical practice. It begins with a review of T1 relaxation physics and how gadolinium enhances the MR signal, followed by GBCA chelate chemistry, structural classification, and risk grouping. Patient evaluation and GBCA selection are also covered, as well as a discussion of appropriate questions to ask in order to screen patients for risk factors and considerations for special populations such as pediatric, pregnant, or breastfeeding patients. The course concludes with an introduction of communication, documentation, and emergency response protocols, highlighting how each member of the MR team contributes to safe GBCA administration.
* This sample course is for reference purposes only. It is not currently available for earning CE credits. To earn ARRT CE credits please subscribe to eRADIMAGING where you will see a complete listing of all active and eligible CE courses.
Enter your email address to receive our new course alerts.